Inventor · disambiguated record
Manja Friese-Hamim
Also filed as: FRIESE-HAMIM MANJA
6 granted patents·8 pending applications·13 citations·filing 2012–2021
74Inventor score
Top patents by PatentIndex Score
14 records- 0184US9809552B2Piperazine derivatives as FASN inhibitorsMERCK PATENT GMBH·Filed 2014·Granted Nov 7, 2017·8 cites·2 claims
- 0274US10093623B2Cyclic amides as MetAP-2 inhibitorsMERCK PATENT GMBH·Filed 2013·Granted Oct 9, 2018·3 cites·5 claims
- 0366US10005756B2Pyrrolidinone derivatives as MetAP-2 inhibitorsMERCK PATENT GMBH·Filed 2015·Granted Jun 26, 2018·1 cites·8 claims
- 0462US10231972B2Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a quinazoline derivativeMERCK PATENT GMBH·Filed 2015·Granted Mar 19, 2019·1 cites·9 claims
- 0554US2023346815A1Lmp7-selective inhibitors for the treatment of blood disorders and solid tumorsMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 0653US2023248695A1Combinations of cancer therapeuticsMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 0746US2019388423A1Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitorMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
- 0842US10532052B2Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitorMERCK PATENT GMBH·Filed 2015·Granted Jan 14, 2020·0 cites·10 claims
- 0941US9283225B2Pyrido-pyrimidine derivativesSTAEHLE WOLFGANG·Filed 2012·Granted Mar 15, 2016·0 cites·13 claims
- 1039US2016331748A1A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of renal cell carcinoma (RCC)MERCK PATENT GMBH·Filed 2014·Application pending·0 cites
- 1139US2016324855A1Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with gefitinibMERCK PATENT GMBH·Filed 2014·Application pending·0 cites
- 1236US2015283137A16-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (HCC)MERCK PATENT GMBH·Filed 2013·Application pending·0 cites
- 1336US2015297594A1Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a MEK inhibitorMERCK PATENT GMBH·Filed 2013·Application pending·0 cites
- 1435US2015044211A1Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with other anti-tumor compoundsMERCK PATENT GMBH·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →